PUMECITINIB

UNII:	5C5U3Z8XBY
Type:	INGREDIENT SUBSTANCE
Formula:	C₁₇H₂₀N₈O₂S
Preferred Substance Name:	PUMECITINIB
InChIKey:	OUXYFMCMGWQWQF-UHFFFAOYSA-N
GSRS Full Record:	5C5U3Z8XBY i

2401057-12-1
2-[3-[3-amino-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]-1-propan-2-ylsulfonylazetidin-3-yl]acetonitrile
3-Azetidineacetonitrile, 3-[3-amino-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-1-[(1-methylethyl)sulfonyl]-
3-[3-Amino-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-1-[(1-methylethyl)sulfonyl]-3-azetidineacetonitrile
Pumecitinib
Pumecitinib [WHO-DD]
pumecitinib [INN]
{3-[3-amino-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H- pyrazol-1-yl]-1-(propane-2-sulfonyl)azetidin-3- yl}acetonitrile

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PUMECITINIB

Synonyms and Mappings

Resources